Reports improved survival in metastatic gastroenteropancreatic neuroendocrine carcinomas from combination chemoIO, suggesting changes in treatment approaches.
Combination chemoIO may improve survival in metastatic GEP-NECs as compared to chemotherapy alone. Results of currently ongoing clinical trials exploring the role of immunotherapy in extrapulmonary NECs may help guide clinical practice in GEP-NECs.
No takes yet. Share an insight, caveat, or question.
Gujarathi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: